Perennial Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Perennial Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12	Closed	-$3K	–	306
2021 Q1	$3K	Hold	12	–	–	﹤0.01%	279
2020 Q4	$1K	Buy	+12	New	+$1.34K	﹤0.01%	247
2020 Q3	–	Sell	-12	Closed	-$1K	–	227
2020 Q2	$1K	Buy	+12	New	+$1.36K	﹤0.01%	224
2019 Q1	–	Sell	-12	Closed	-$1K	–	202
2018 Q4	$1K	Buy	+12	New	+$1.57K	﹤0.01%	213

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Perennial Advisors's GWPH Position: Q2 2021 in Review

Perennial Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 12 shares — an estimated $3K sold.

Perennial Advisors first reported a position in GWPH in Q4 2018 and held it in 4 quarters. The position peaked at $3K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Perennial Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Perennial Advisors sold 12 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $3K.
Perennial Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 4 quarters.
Perennial Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Perennial Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.